Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro

Wang,Haibo; Ji,Xiaojun; Liu,Xiangping; Yao,Ruyong; Chi,Jingwei; Liu,Shihai; Wang,Yu; Cao,Weihong; Zhou,Quan

doi:10.3892/or.2013.2798

Lentivirus-mediated inhibition of USP39 suppresses the growth of breast cancer cells in vitro

Authors:
- Haibo Wang
- Xiaojun Ji
- Xiangping Liu
- Ruyong Yao
- Jingwei Chi
- Shihai Liu
- Yu Wang
- Weihong Cao
- Quan Zhou
View Affiliations

Affiliations: Center of Diagnosis and Treatment of Breast Disease, The Affiliated Hospital of the Medical College, Qingdao University, Qingdao, Shandong 266003, P.R. China, Neurological Department of Internal Medicine Emergency, The Affiliated Hospital of the Medical College, Qingdao University, Qingdao, Shandong 266003, P.R. China, Central Laboratory of Molecular Biology, The Affiliated Hospital of the Medical College, Qingdao University, Qingdao, Shandong 266003, P.R. China
Published online on: October 14, 2013 https://doi.org/10.3892/or.2013.2798
Pages: 2871-2877

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Worldwide, breast cancer is the most frequently diagnosed life-threatening cancer in women and is the leading cause of cancer-related mortality among women. It is extremely rare but highly lethal in men. The deubiquitinating enzyme USP39 plays important roles in mRNA processing, and our previous data showed that high levels of USP39 are selectively present in different types of human breast tumor cells. The potential of USP39 as a therapeutic target for breast cancer was investigated. The expression levels of USP39 protein in 23 breast cancer specimens were quantified using an immunohistochemical assay and were found to have high levels in human breast cancer tissues when compared to these levels in normal breast tissues. In the breast cancer cell line MCF-7, USP39 expression was knocked down by a lentiviral short hairpin RNA (shRNA) delivery system. The RNA interference (RNAi)-mediated downregulation of USP39 expression markedly reduced the proliferative and colony forming ability of MCF-7 cells. In addition, the inhibition of USP39 induced G0/G1-phase arrest and apoptosis of the cells. These results suggest that USP39 may act as an oncogenic factor in breast cancer and could be a potential molecular target for breast cancer gene therapy.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar
2	Sinha D, Biswas J, Sung B, Aggarwal BB and Bishayee A: Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Curr Drug Targets. 13:1799–1819. 2012. View Article : Google Scholar : PubMed/NCBI
3	Allgayer H and Fulda S: An introduction to molecular targeted therapy of cancer. Adva Med Sci. 53:130–138. 2008.PubMed/NCBI
4	Pickart CM and Eddins MJ: Ubiquitin: structures, functions, mechanisms. Biochim Biophys Acta. 1695:55–72. 2004. View Article : Google Scholar : PubMed/NCBI
5	Pickart CM and Fushman D: Polyubiquitin chains: polymeric protein signals. Curr Opin Chem Biol. 8:610–616. 2004. View Article : Google Scholar : PubMed/NCBI
6	Ohta T and Fukuda M: Ubiquitin and breast cancer. Oncogene. 23:2079–2088. 2004. View Article : Google Scholar : PubMed/NCBI
7	Wilkinson KD: Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11:1245–1256. 1997.PubMed/NCBI
8	Nijman SM, Luna-Vargas MP, Velds A, et al: A genomic and functional inventory of deubiquitinating enzymes. Cell. 123:773–786. 2005. View Article : Google Scholar : PubMed/NCBI
9	Reyes-Turcu FE, Ventii KH and Wilkinson KD: Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem. 78:363–397. 2009. View Article : Google Scholar : PubMed/NCBI
10	Makarova OV, Makarov EM and Luhrmann R: The 65 and 110 kDa SR-related proteins of the U4/U6. U5 tri-snRNP are essential for the assembly of mature spliceosomes. EMBO J. 20:2553–2563. 2001. View Article : Google Scholar : PubMed/NCBI
11	van Leuken RJ, Luna-Vargas MP, Sixma TK, Wolthuis RM and Medema RH: Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of aurora B. Cell Cycle. 7:2710–2719. 2008.PubMed/NCBI
12	Rios Y, Melmed S, Lin S and Liu NA: Zebrafish usp39 mutation leads to rb1 mRNA splicing defect and pituitary lineage expansion. PLoS Genet. 7:e10012712011. View Article : Google Scholar : PubMed/NCBI
13	Izquierdo M: Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Ther. 12:217–227. 2005. View Article : Google Scholar : PubMed/NCBI
14	Qin XF, An DS, Chen IS and Baltimore D: Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA. 100:183–188. 2003. View Article : Google Scholar : PubMed/NCBI
15	Chen X, Zhang B and Fischer JA: A specific protein substrate for a deubiquitinating enzyme: liquid facets is the substrate of Fat facets. Genes Dev. 16:289–294. 2002. View Article : Google Scholar : PubMed/NCBI
16	Sakurai M, Ayukawa K, Setsuie R, et al: Ubiquitin C-terminal hydrolase L1 regulates the morphology of neural progenitor cells and modulates their differentiation. J Cell Sci. 119:162–171. 2006. View Article : Google Scholar : PubMed/NCBI
17	Yang JM: Emerging roles of deubiquitinating enzymes in human cancer. Acta Pharmacologica Sin. 28:1325–1330. 2007. View Article : Google Scholar : PubMed/NCBI
18	Paulsson K, Békassy AN, Olofsson T, Mitelman F, Johansson B and Panagopoulos I: A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42. Leukemia. 20:224–229. 2006. View Article : Google Scholar : PubMed/NCBI
19	Kim J, Kim WJ, Liu Z, Loda M and Freeman MR: The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer. Cell Cycle. 11:1123–1130. 2012. View Article : Google Scholar : PubMed/NCBI
20	Stevenson LF, Sparks A, Allende-Vega N, Xirodimas DP, Lane DP and Saville MK: The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J. 26:976–986. 2007. View Article : Google Scholar : PubMed/NCBI
21	Nijman SM, Huang TT, Dirac AM, et al: The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol Cell. 17:331–339. 2005. View Article : Google Scholar : PubMed/NCBI
22	Huang TT, Nijman SM, Mirchandani KD, et al: Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol. 8:339–347. 2006. View Article : Google Scholar : PubMed/NCBI
23	Zhang D, Zaugg K, Mak TW and Elledge SJ: A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell. 126:529–542. 2006. View Article : Google Scholar : PubMed/NCBI
24	Popov N, Herold S, Llamazares M, Schulein C and Eilers M: Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell Cycle. 6:2327–2331. 2007. View Article : Google Scholar : PubMed/NCBI
25	Schoenfeld AR, Apgar S, Dolios G, Wang R and Aaronson SA: BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol Cell Biol. 24:7444–7455. 2004. View Article : Google Scholar : PubMed/NCBI
26	Li M, Chen D, Shiloh A, et al: Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 416:648–653. 2002. View Article : Google Scholar : PubMed/NCBI
27	Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C and Vogelstein B: Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature. 428:1 p following 486. 2004. View Article : Google Scholar : PubMed/NCBI
28	Yuan J, Luo K, Zhang L, Cheville JC and Lou Z: USP10 regulates p53 localization and stability by deubiquitinating p53. Cell. 140:384–396. 2010. View Article : Google Scholar : PubMed/NCBI
29	Lygerou Z, Christophides G and Seraphin B: A novel genetic screen for snRNP assembly factors in yeast identifies a conserved protein, Sad1p, also required for pre-mRNA splicing. Mol Cell Biol. 19:2008–2020. 1999.PubMed/NCBI